UVstocks.io is committed to consistently tracking and reporting on the most undervalued stocks in the S&P 500: the gold standard barometer of American capitalism, delivering curated daily info to your inbox. Give the gift of insight to your friends, family and colleagues by sharing the uvstocks.io link and this article today.

At UVstocks.io, we continue to add stock data sources beyond the ones that generate our daily Convergent Stock Rating (CSR) list. This week we’re showcasing insights from some of those expanded sources (listed just below) and highlight a rare set of stocks that every major site rates a “Buy” (or “Strong Buy”) — a true needle in the haystack. Out of the 503 stocks in the S&P 500, only six met that standard in our screens this week.


In addition to Investopedia, Google Finance, WSJ, Market Watch, CNN Money, Barron’s, Moody’s, Business Insider:


• Stock Analysis

• Ticker Nerd

• MarketBeat

• TipRanks

• CNBC

• Zacks

• Benzinga

• Yahoo Finance

• Webull

• Alpha Spread


And here’s the kicker: of those six, just one stock is also undervalued according to Alpha Spread’s intrinsic value model. Note: data as of August 15, 2025 market close.

Takeaway

Consensus is rare. True undervaluation even rarer. GE HealthCare (GEHC) remains the lone stock with full analyst alignment and a valuation gap, making it the kind of opportunity UVstocks is uniquely equipped to surface. If you’d like access to this enhanced cross-site analytics platform, it’s available through our Professional subscription tier —just shoot me an email, and I’d be happy to share details.


“One of the Internet's strengths is its ability to help consumers find the right needle in a digital haystack of data.”— Jared Sandberg


Not sure where to start or know someone that could use the help? Help them find needles in haystacks by sending them this article and the UVstocks.io link.


P.S. I'm sharing some investment information, but it's important to remember that what I'm providing is for informational purposes only and should not be construed as financial advice.


Happy Investing,

John


If someone shared this newsletter with you, you can subscribe for yourself here.